Molecular Templates, Inc. (MTEM) Financials

MTEM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2024 26.7 million 19.6 million
March 31, 2024 27.1 million 21.2 million
Dec. 31, 2023 35.4 million 31.2 million
Sept. 30, 2023 44.1 million 37.3 million

MTEM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2024 -5.9 million 722000
March 31, 2024 -5.2 million 1.1 million
Dec. 31, 2023 -5.3 million 1.4 million
Sept. 30, 2023 -7.5 million 1.2 million

MTEM Net Income

No data available :(

MTEM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2024 9.7 million 8.4 million 11.0 million
March 31, 2024 6.8 million 9.1 million 11.6 million
Dec. 31, 2023 11.5 million 9.7 million 12.2 million
Sept. 30, 2023 15.8 million 10.4 million 12.8 million

MTEM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2024 6.6 million
March 31, 2024 7.0 million
Dec. 31, 2023 5.4 million
Sept. 30, 2023 5.1 million

MTEM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2024 - 5.4 million 3.5 million 1.1 million
March 31, 2024 - 7.4 million 2.6 million -1.2 million
Dec. 31, 2023 - 8.8 million 2.3 million -1.3 million
Sept. 30, 2023 - 5.7 million 4.3 million -

MTEM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2024 572000 5.4 million
March 31, 2024 11.1 million 1.2 million
Dec. 31, 2023 7.0 million 1.3 million
Sept. 30, 2023 6.8 million 1.5 million

MTEM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MTEM

Price: $0

52 week price:
0.00
1.59

Payout Ratio Range:
-13.85%
-0.03%

Earnings Per Share: -3.05 USD

P/E Ratio: 0.00

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 75100

Ebitda: -5.8 million

Market Capitalization: 658

Links: